My Epionce · Epionce

Select Gift

  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine
Signup ›
  • What's New

  • The Spring Sale Shop Now

    The Spring Sale

  • Discover our New Clay Mask Go >

    Discover our New Clay Mask

  • Are LED Face Masks Overhyped? Learn >

    Are LED Face Masks Overhyped?
  • Epionce Near You   Nearby  
  • Login
The Spring Sale Discover our New Clay Mask Are LED Face Masks Overhyped?
Epionce Logo Epionce Logo
  • 0

  • The Spring Sale Shop Now

    Discover our New Clay Mask Go >

    Are LED Face Masks Overhyped? Learn >

  • Epionce Near You  
  • Login

    No Account? Signup ›

CONSUMER WARNING: Counterfeit Epionce Products
  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine

Login

Don't have an account? Signup.

Forgot Password?

  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

Sign up for emails with the latest news, offers, and announcements from Epionce:

This field is for validation purposes and should be left unchanged.
  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

The U.S. Food and Drug Administration (FDA) defines cosmetics as "articles...applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance." The majority of Epionce® products described on this website are intended to meet this definition. These Epionce® products and their associated statements have not been approved or evaluated by the FDA and are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition.

Epionce Daily Shield Tinted SPF 50 is considered an over-the-counter drug product. It is formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 C.F.R. Part 352.

USA Canada United Kingdom Hong Kong Japan Poland The Netherlands Estonia Finland Latvia Switzerland Ireland Sweden Norway Czech Armenia

Privacy Policy | Legal | Sitemap

© 2026 Episciences, Inc.
All Rights Reserved Worldwide